NCT03680066

Brief Summary

This protocol will help better define whether patients with peanut and/or tree nut food allergy can tolerate traces in products with precautionary allergen labelling.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2018

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 25, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 21, 2018

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 28, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 28, 2023

Completed
Last Updated

December 5, 2023

Status Verified

November 1, 2023

Enrollment Period

5.7 years

First QC Date

July 25, 2018

Last Update Submit

November 28, 2023

Conditions

Keywords

Peanut allergyTree Nut allergyPrecautionary allergen labelingMay contain tracesAllergen threshold

Outcome Measures

Primary Outcomes (1)

  • Result of the food challenges with foods labelled with "may contain traces" (tolerated or reacted).

    Result of the food challenges with foods labelled with "may contain traces" (tolerated or reacted).

    At study entry

Secondary Outcomes (4)

  • Tolerance to foods labelled with "may contain traces" eaten normally during a 3 months follow-up.

    During 3 months follow-up

  • Frequency of reactions to foods labelled with "may contain traces" eaten normally during a 3 months follow-up.

    During 3 months follow-up

  • Severity of reactions to foods labelled with "may contain traces" eaten normally during a 3 months follow-up.

    During 3 months follow-up

  • Changes of quality of life after 3 months without restriction of foods labelled with "may contain traces", compared to baseline when restricting.

    At entry and after 3 months

Study Arms (1)

Foods with traces

EXPERIMENTAL

Oral food challenge with foods with traces

Other: Oral food challenge to foods with traces

Interventions

Subjects will undergo an open food challenge to 3 processed foods labeled with "may contain traces". The following foods (similar for all patients) will be given in one dose in the size of a regular serving: * cookies, max 30 g; * chocolate, max 30 g; * breakfast cereals, max 50 g. Each meal will be administered with a 1 hour observation period in between and at the end.

Foods with traces

Eligibility Criteria

Age2 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Tree nut or peanut allergy documented by:
  • Positive skin prick tests (SPTs) to peanut and/or tree nuts
  • Positive specific IgE (sIgE) to peanut and/or tree nuts ( ≥0.35 kU/L)
  • A recent (\< 1 year) positive food challenge, reacting to the dose of 30 mg of proteins or below.
  • Parent/Legal guardian has been informed about the study and has signed Informed Consent Form

You may not qualify if:

  • History of a moderate or severe reaction during a food challenge with a dose of 30 mg of proteins or less.
  • Expected non-adherence to the study protocol.
  • Severe or uncontrolled asthma.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pediatric Allergy Unit - University Hospitals of Geneva

Geneva, 1205, Switzerland

Location

MeSH Terms

Conditions

Food HypersensitivityPeanut HypersensitivityNut Hypersensitivity

Condition Hierarchy (Ancestors)

Hypersensitivity, ImmediateHypersensitivityImmune System DiseasesNut and Peanut Hypersensitivity

Study Officials

  • Philippe Eigenmann, MD

    University Hospitals of Geneva

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head, Pediatric Allergy Unit, Department of Pediatrics

Study Record Dates

First Submitted

July 25, 2018

First Posted

September 21, 2018

Study Start

April 1, 2018

Primary Completion

November 28, 2023

Study Completion

November 28, 2023

Last Updated

December 5, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations